Parkinson's Disease (PD) is a progressive neurodegenerative disorder that predominantly affects the dopaminergic neurons in the substantia nigra, causing motor and non-motor symptoms. The pathogenesis of PD is multifactorial, involving genetic and environmental factors. This complex disorder requires a comprehensive understanding for optimal patient management.
PD affects approximately 1% of individuals over the age of 60, with a higher prevalence in males. Risk factors include age, genetic predisposition, exposure to certain pesticides, and history of head injury. Conversely, caffeine intake and tobacco use appear to have a protective effect.
The hallmark of PD is the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to dopamine deficiency in the striatum. This results in an imbalance in the direct and indirect pathways of the basal ganglia, causing motor symptoms. The presence of Lewy bodies, composed of alpha-synuclein, is another characteristic feature.
PD presents with both motor (bradykinesia, rigidity, rest tremor, postural instability) and non-motor symptoms (depression, constipation, sleep disturbances). Diagnosis is primarily clinical, supported by response to dopaminergic therapy. Neuroimaging can aid in differentiating PD from other parkinsonian syndromes.
Treatment of PD is symptomatic, with levodopa being the most effective medication for motor symptoms. Non-motor symptoms are managed with a multidisciplinary approach. Deep brain stimulation can be considered in patients with motor complications not adequately controlled by medication.
PD is a complex neurodegenerative disorder with a multifactorial pathogenesis. A comprehensive understanding of its epidemiology, pathophysiology, clinical presentation, and treatment options is essential for healthcare professionals to provide optimal patient care.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation